SEC Form 4 research
| Issuer | Immunovant, Inc. |
|---|---|
| Tickers | IMVT, HSAC, HSACU |
| Reporting owners | 34 |
| Officers and directors | 18 |
| Last public filing | 2026-10-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-09 | 2026-10-07 | Stout Jay S | S | 1,596 | $32.06 | Not reported |
| 2026-10-09 | 2026-10-07 | Stout Jay S | S | 2,213 | $32.06 | Not reported |
| 2026-10-09 | 2026-10-07 | Van Tuyl Christopher | S | 1,327 | $32.06 | Not reported |
| 2026-10-09 | 2026-10-07 | Gloria Melanie | S | 2,241 | $32.06 | Not reported |
| 2026-10-05 | 2026-10-02 | Venker Eric | S | 3,506 | $34.11 | Not reported |
| 2026-09-25 | 2026-09-23 | Van Tuyl Christopher | S | 2,846 | $36.36 | Not reported |
| 2026-08-28 | 2026-08-28 | Pande Atul | S | 1,500 | $43.27 | Not reported |
| 2026-08-21 | 2026-08-20 | Gloria Melanie | S | 3,056 | $44.16 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.